Comerica Bank’s Pliant Therapeutics PLRX Stock Holding History

Comerica Bank’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$7	Sell	6 -8	-57%	-$12	﹤0.01%	3705
2025 Q3	$21	Hold	14	–	–	﹤0.01%	3704
2025 Q2	$16	Hold	14	–	–	﹤0.01%	3686
2025 Q1	$19	Sell	14 -77	-85%	-$467	﹤0.01%	3678
2024 Q4	$1.2K	Hold	91	–	–	﹤0.01%	3552
2024 Q3	$1.02K	Hold	91	–	–	﹤0.01%	3572
2024 Q2	$978	Hold	91	–	–	﹤0.01%	3583
2024 Q1	$1.36K	Hold	91	–	–	﹤0.01%	3590
2023 Q4	$1.65K	Sell	91 -77	-46%	-$1.17K	﹤0.01%	3561
2023 Q3	$2.91K	Buy	+168	New	+$2.91K	﹤0.01%	3498

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Comerica Bank's PLRX Position: Q4 2025 in Review

Comerica Bank reduced its Pliant Therapeutics (PLRX) stake by 57% in Q4 2025, selling an estimated $12 and leaving 6 shares worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #3705.

Comerica Bank first reported a position in PLRX in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.91K in Q3 2023. 96 funds tracked by Wall St. Rank hold PLRX as of Q4 2025.

Comerica Bank held 6 shares of Pliant Therapeutics worth $7 as of Q4 2025.
Comerica Bank sold 8 Pliant Therapeutics shares in Q4 2025, an estimated $12.
Pliant Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3705 holding.
Comerica Bank first reported a position in Pliant Therapeutics in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Pliant Therapeutics position peaked at $2.91K in Q3 2023.
96 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.